Three of the found variants, c.444+1G>A, c.1100del, and c.349A>G, were previously described in the Slovenian population amongst the most frequent CHEK2 pathogenic variants in Slovenian CHEK2 positive breast cancer patients52. This evidence concerns the gene CHEK2 and breast carcinoma.